Trademark: 98123485
Word
REGENXBIO
Status
Pending
Status Code
641
Status Date
Wednesday, April 17, 2024
Serial Number
98123485
Mark Type
4
Filing Date
Wednesday, August 9, 2023

Trademark Owner History

Classifications
5 Biotechnological platform technology, namely, biological nanoparticles, recombinant viruses, and adenoviruses for gene delivery to biological cells that includes recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy, RNA interference (RNAi), and cell therapy

Trademark Events
Apr 10, 2024
Assigned To Examiner
Apr 17, 2024
Notification Of Non-Final Action E-Mailed
Aug 12, 2023
New Application Entered
Sep 7, 2023
New Application Office Supplied Data Entered
Apr 17, 2024
Non-Final Action Written
Apr 17, 2024
Non-Final Action E-Mailed
Jul 12, 2024
Teas Response To Office Action Received

Trademark Alertz updated from USPTO on 2030-01-24